Academic Detailing to Improve Laboratory Testing Among Outpatient Medication Users

Purpose: To determine whether group academic detailing with performance feedback increases recommended laboratory monitoring among outpatients dispensed medications. Methods: Thirty-eight primary care practices in 3 states were randomized to group academic detailing with physician-level performance feedback (intervention) or a control group. Adjusted differences in creatinine and potassium testing between intervention and control group patients with a new or continuing dispensing for angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs), diuretics, or digoxin were evaluated using generalized estimating equation approaches. Results: Monitoring among patients with an initial ACE/ARB and diuretic dispensing significantly improved with the intervention [odds ratio (OR) = 1.22, 95% confidence interval (CI): 1.08–1.38; and OR = 1.25, 95% CI: 1.08–1.44, respectively). The intervention also significantly improved monitoring among patients with a continuing dispensing for an ACE/ARB (OR = 1.39, 95% CI: 1.11–1.74) or a diuretic (OR = 1.28, 95% CI: 1.02–1.60). Adjusted differences in testing rates between study arms were modest (ranging from 2.5% to 4.9%). No significant differences in monitoring by study arm were detected among patients dispensed digoxin. Conclusions: The impact of a group academic detailing program with feedback on recommended laboratory monitoring among medication users was modest. Yet, given the numbers of outpatients dispensed medications for which laboratory monitoring is recommended, group academic detailing may offer 1 method by which outpatient medication safety can be significantly improved.

[1]  A D Oxman,et al.  Educational outreach visits: effects on professional practice and health care outcomes. , 2007, The Cochrane database of systematic reviews.

[2]  Richard Platt,et al.  Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers , 2007, Pharmacoepidemiology and drug safety.

[3]  Nikki M. Carroll,et al.  Liver and Thyroid Monitoring in Ambulatory Patients Prescribed Amiodarone in 10 HMOs , 2006, Journal of managed care pharmacy : JMCP.

[4]  Richard Platt,et al.  Potential Drug–Drug Interactions in the Outpatient Setting , 2006, Medical Care.

[5]  Dean F. Sittig,et al.  The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. , 2006, Archives of internal medicine.

[6]  Dean F Sittig,et al.  Reducing warfarin medication interactions: an interrupted time series evaluation. , 2006, Archives of internal medicine.

[7]  Robert L Davis,et al.  Monitoring of drugs with a narrow therapeutic range in ambulatory care. , 2006, The American journal of managed care.

[8]  Nidhi R. Shah,et al.  Adherence to black box warnings for prescription medications in outpatients. , 2006, Archives of internal medicine.

[9]  Steven R. Simon,et al.  Laboratory monitoring of drugs at initiation of therapy in ambulatory care , 2005, Journal of General Internal Medicine.

[10]  Robert L Davis,et al.  Baseline Laboratory Monitoring of Cardiovascular Medications in Elderly Health Maintenance Organization Enrollees , 2005, Journal of the American Geriatrics Society.

[11]  C. Marano,et al.  To err is human. Building a safer health system , 2005 .

[12]  K. Chan,et al.  Development of a Multipurpose Dataset to Evaluate Potential Medication Errors in Ambulatory Settings , 2005 .

[13]  L. Solberg,et al.  Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data. , 2004, The American journal of managed care.

[14]  E. Hahn,et al.  Readmissions and adverse drug reactions in internal medicine: the economic impact , 2004, Journal of internal medicine.

[15]  P. Glassman,et al.  Retrospective Drug Utilization Review: Incidence of Clinically Relevant Potential Drug-Drug Interactions in a Large Ambulatory Population , 2003, Journal of managed care pharmacy : JMCP.

[16]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[17]  Joshua Borus,et al.  Adverse drug events in ambulatory care. , 2003, The New England journal of medicine.

[18]  A. Laupacis,et al.  Drug-drug interactions among elderly patients hospitalized for drug toxicity. , 2003, JAMA.

[19]  D. Bates,et al.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting. , 2003, JAMA.

[20]  W. Wu,et al.  Evaluation of outpatient adverse drug reactions leading to hospitalization. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[21]  J. Avorn,et al.  Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing , 2001, British medical journal.

[22]  A. Figueiras,et al.  One-to-One Versus Group Sessions to Improve Prescription in Primary Care: A Pragmatic Randomized Controlled Trial , 2001, Medical care.

[23]  V. Diwan,et al.  Influencing prescribing for urinary tract infection and asthma in primary care in Sweden: a randomized controlled trial of an interactive educational intervention. , 1999, Journal of clinical epidemiology.

[24]  Kelly M. Smith,et al.  Drug-related problems in emergency department patients. , 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[25]  B. Santoso,et al.  Small group intervention vs formal seminar for improving appropriate drug use. , 1996, Social science & medicine.

[26]  G Tomson,et al.  Effects of "group detailing" on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish primary care. , 1995, Journal of clinical epidemiology.

[27]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[28]  S B Soumerai,et al.  Principles of educational outreach ('academic detailing') to improve clinical decision making. , 1990, JAMA.

[29]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[30]  P. Maurette,et al.  [To err is human: building a safer health system]. , 2002, Annales francaises d'anesthesie et de reanimation.

[31]  Andrew P. Hull,et al.  The Relationship between Early Childhood Blood Lead Levels and Performance on End-of-Grade Tests , 2007, Environmental health perspectives.